✦ LIBER ✦

Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: Clonal evolution during lamivudine plus adefovir therapy

✍ Scribed by Kim, Soon Sun; Cho, Sung Won; Kim, Soo-Ok; Hong, Sun Pyo; Cheong, Jae Youn

Book ID: 118763103
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 479 KB
Volume: 85
Category: Article
ISSN: 0146-6615
DOI: 10.1002/jmv.23440

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dynamics of lamivudine-resistant hepatit

Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy

✍ Samreen Ijaz; Catherine Arnold; Samir Dervisevic; Jana Mechurova; Nick Tatman; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

## Abstract Adefovir dipivoxil has been used alone or together with lamivudine to suppress lamivudine‐resistant hepatitis B virus (HBV). However, the dynamics of HBV populations under different selection pressures and their impact on treatment outcome are poorly understood. Pyrosequencing® was appl

Lamivudine plus adefovir combination the

Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis

✍ Yun-Jian Sheng; Jun-Ying Liu; Shi-Wen Tong; Huai-Dong Hu; Da-Zhi Zhang; Peng Hu; 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 236 KB

Two rescue therapies in lamivudine-resis

Two rescue therapies in lamivudine-resistant patients with chronic hepatitis B in the central China: adefovir monotherapy and adefovir plus lamivudine

✍ Wang, Ming; Yuan, Leyong; Qiao, Bin; Li, Yan 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 275 KB

Antiviral efficacy of combination therap

Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance

✍ Hyo-Joon Yang; Jeong-Hoon Lee; Yoon Jun Kim; Jung-Hwan Yoon; Hyo-Suk Lee 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract There is little clinical information on the management of hepatitis B virus (HBV) that is resistant to multiple drugs including entecavir (ETV). The present retrospective cohort study assessed the antiviral efficacy of ETV/adefovir dipivoxil (ADV) combination therapy for ETV‐resistant H

Factors associated with the virological

Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine

✍ Tetsuya Hosaka; Fumitaka Suzuki; Yoshiyuki Suzuki; Satoshi Saitoh; Masahiro Koba 📂 Article 📅 2007 🏛 Springer Japan 🌐 English ⚖ 213 KB

Efficacy of adefovir add-on lamivudine r

Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B

✍ Han Jak Ryu; Jung Min Lee; Sang Hoon Ahn; Do Young Kim; Myoung Ha Lee; Kwang-Hyu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## Abstract No study has reported on the comparative effect of adefovir (ADV) add‐on lamivudine (LAM) versus switching to entecavir (ETV) in LAM‐resistant patients with chronic hepatitis B. From October 2007 to September 2008, 92 consecutive LAM‐resistant patients were enrolled (47 LAM + ADV and 45